Novo Nordisk

🖥️

Description

Novo Nordisk is a leading international healthcare company founded in 1923, owned by a foundation, and headquartered in Denmark. Our mission is to drive change to overcome diabetes and other serious chronic diseases such as obesity, as well as growth disorders and rare haemorrhagic diseases (haemophilia, Glanzmann thrombasthenia). Novo Nordisk employs more than 69,000 people in 80 countries and its healthcare solutions are available in 170 countries. In France, our subsidiary based in Paris - La Défense has approximately 370 employees. The Chartres site specialises in the production of insulin cartridges and vials, as well as the assembly and packaging of pre-filled injection pens. In 2022, new investments enabled the installation of a dedicated module for packaging a GLP-1 (glucagon-like peptide-1) analogue for the treatment of type 2 diabetes. With around 1,750 employees, Novo Nordisk's Chartres production site is the leading private employer in the Eure-et-Loir region. Every day, around 10 million diabetics around the world benefit from a ‘Made in Chartres’ healthcare solution.